This bill amends Section 41-351 of the Idaho Code to update the reporting requirements for entities participating in the federal 340B drug pricing program. Key changes include the requirement for 340B covered entities to report information based on the most recent fiscal year instead of the previous calendar year. The bill specifies that these entities must provide details such as the name of the covered entity, aggregate acquisition costs for prescription drugs obtained under the 340B program, and the savings generated from these prescriptions. Additionally, it clarifies that the data must be reported through a secure website portal and emphasizes the confidentiality of the submitted information.

The bill also modifies the reporting process by removing the requirement to categorize data by payer type, which included commercial, Medicaid, and Medicare. Instead, it mandates the state controller's office to prepare an aggregated report of the submitted data by November 15 each year and submit it to the legislative council in an electronic format, while also making it available on the transparent Idaho website. The attorney general is granted the authority to use the reported information for investigating Medicaid fraud and ensuring compliance with health administration requirements. An emergency clause is included, making the act effective on July 1, 2026.

Statutes affected:
Bill Text: 41-351